… The same company that The Michael J. Fox Foundation has funded for a … announced positive results from a study of its drug aiming to slow Alzheimer’s progression. Austrian-based biotech … and more effect in early-disease patients. AFFiRiS is also testing a Parkinson’s-modifying treatment. MJFF funded the …

… (MJFF) convened the first-ever annual meeting of its  Targets to Therapies (T2T) initiative, bringing together more than … to a virtual format, the energy and engagement of the T2T community were undeterred. Across plenary sessions and …

… NY —The Michael J. Fox Foundation for Parkinson’s Research today announced $5.2 million in support for two studies … to an estimated 13 to 40 percent of Parkinson’s cases, compared with an estimated one to two percent in the general … and genetic processes, providing critical clues about how best to clinically test future therapeutics targeting …

… Study Rationale:  Inflammation is recognized as a factor in the progression of Parkinson’s disease (PD). The … PINK1 and Parkin are involved in eliminating damaged cell components such as mitochondria. Mutations in PINK1 and … contents when stressed, which cells activate STING, and how this inflammatory response spreads within and between …

… Funday event this past April, the Team Fox YPs are excited to host a more intimate crowd for a formal evening of live … thought there was a great opportunity among the YP set to get dressed up, kick off the holiday season and celebrate our accomplishments of this year, all while raising money and …

… Fox Foundation announced that Team Fox ™ , its grassroots community program, will be participating in this year’s ING … the marathon’s expanded charity program. “We are grateful to all the athletes who have joined Team Fox and devoted … the finish line,” said Team Fox runner Eugene Gurkoff. “However, sharing this experience with the other members of …